Hematology/Oncology

Top Story

Physicians who do not certify more likely to receive disciplinary actions

April 28, 2016

An analysis of data sets found that 95% of internal medicine residents achieve certification through the American Board of Internal Medicine, according to findings published in Academic Medicine.

Rebecca S. Lipner, PhD, senior vice president of assessment and research for the ABIM, and colleagues reported that the remaining 5% of physicians were more likely to receive disciplinary actions from state medical board.

Meeting News CoverageVideo

VIDEO: Multivitamin use before breast cancer diagnosis may reduce peripheral neuropathy risk

April 28, 2016
NEW ORLEANS — Multivitamin supplement use appeared associated with a reduced risk for
In the Journals

Monthly cost of oral cancer drugs rises steadily over time

April 28, 2016
The cost of oral cancer drugs in their first year on the market has increased significantly since the year 2000, according to a research letter published in JAMA
In the Journals

Cancer diagnosis increases risk for mental disorders, psychiatric medication use

April 28, 2016
Patients diagnosed with cancer faced an increased risk for common mental disorders — such as depression, anxiety and stress reaction/adjustment disorder —…
Video

VIDEO: Tumor-infiltrating lymphocytes may predict response to immunotherapy in breast cancer

April 28, 2016
Determining which tumor-infiltrating lymphocytes may predict response to immunotherapy among patients with breast cancer, and identifying biomarkers that indicate cell…
More News Headlines »
CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
Video
Meeting News Coverage

VIDEO: Ado-trastuzumab emtansine plus pertuzumab effective for HER-2–positive breast cancer

April 19, 2016
More »
Featured
At Issue: Multiple Myeloma Resource Center

At Issue: Multiple Myeloma Resource Center

CME Video

World Lung Updates: Immunotherapy in NSCLC

This activity is supported by an educational grant from Genentech, Inc and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan morganatic-roan